The weekly litigation news digest is live. Subscribe now

IP Verse

Dosing Regimen Of Anti-Alpha4Beta7-Antibodies

Patent No. EP3329965 (titled "Dosing Regimen Of Anti-Alpha4Beta7-Antibodies") was filed by Millennium Pharmaceuticals on May 2, 2012. The application was issued on Mar 19, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTDec 19, 2025LEPTHIEN
STORZDec 19, 2025MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB
ABEL & IMRAYDec 18, 2025ABEL & IMRAY
ADVANZ PHARMA SERVICES UKDec 18, 2025ELKINGTON AND FIFE
FRESENIUS KABI SWISSBIOSIMDec 18, 2025D YOUNG
BRAND MURRAY FULLERDec 17, 2025BRAND MURRAY FULLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3329965

MILLENNIUM PHARMACEUTICALS
Application Number
EP18150968A
Filing Date
May 2, 2012
Status
Granted And Under Opposition
Feb 14, 2025
Publication Date
Mar 19, 2025
External Links
Slate, EP3329965B1, Google Patents